Literature DB >> 10438841

Envelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulation.

E Vicenzi1, P P Bordignon, P Biswas, A Brambilla, C Bovolenta, M Cota, F Sinigaglia, G Poli.   

Abstract

The human immunodeficiency virus (HIV) replicates in activated CD4(+) T lymphocytes. However, only CD4(+) Th2 and Th0, but not Th1, CD4(+) T-cell clones have been reported to efficiently support HIV-1 replication. This dichotomous pattern was further investigated in the present study in Th1, Th2, or Th0 cell lines derived from umbilical human cord blood and in T-cell clones obtained from the peripheral blood mononuclear cells (PBMC) of healthy adults. Both primary and laboratory-adapted HIV-1 strains with CCR5 as the exclusive entry coreceptor (R5 viruses) efficiently replicated in Th1, Th2, and Th0 cells. In sharp contrast, CXCR4-dependent (X4) viruses poorly replicated in both polarized and unpolarized CD4(+) T cells, including adults' PBMC infected several days after mitogenic stimulation. Unlike the X4 HIV-1(NL4-3), a chimera in which the env gene had been replaced with that of the R5 HIV-1(NL(AD8)), efficiently replicated in both Th1 and Th2 cells. This X4-dependent restriction of HIV replication was not explained by either the absence of functional CXCR4 on the cell surface or by the inefficient viral entry and reverse transcription. T-cell receptor stimulation by anti-CD3 monoclonal antibodies fully rescued X4 HIV-1 replication in both Th1 and Th2 cells, whereas it did not alter the extent and kinetics of R5 HIV-1 spreading. Thus, R5 HIVs show a replicative advantage in comparison to X4 viruses in their ability to efficiently propagate among suboptimally activated T lymphocytes, regardless of their polarized or unpolarized functional profiles. This observation may help to explain the absolute predominance of R5 HIVs over X4 viruses observed after viral transmission and during early-stage disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10438841      PMCID: PMC104278     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  In-vivo anti-CD3-induced HIV-1 viraemia.

Authors:  K Brinkman; F Huysmans; J M Galama; C A Boucher
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

2.  Dual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression.

Authors:  A Valentin; W Lu; M Rosati; R Schneider; J Albert; A Karlsson; G N Pavlakis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

Review 3.  Chemokine receptors: keys to AIDS pathogenesis?

Authors:  D R Littman
Journal:  Cell       Date:  1998-05-29       Impact factor: 41.582

4.  1,25-Dihydroxyvitamin D3 upregulates functional CXCR4 human immunodeficiency virus type 1 coreceptors in U937 minus clones: NF-kappaB-independent enhancement of viral replication.

Authors:  P Biswas; M Mengozzi; B Mantelli; F Delfanti; A Brambilla; E Vicenzi; G Poli
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

5.  Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection.

Authors:  B Chackerian; E M Long; P A Luciw; J Overbaugh
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  Determinant in human immunodeficiency virus type 1 for efficient replication under cytokine-induced CD4(+) T-helper 1 (Th1)- and Th2-type conditions.

Authors:  Y Suzuki; Y Koyanagi; Y Tanaka; T Murakami; N Misawa; N Maeda; T Kimura; H Shida; J A Hoxie; W A O'Brien; N Yamamoto
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

7.  Enhanced HIV expression during Th2-oriented responses explained by the opposite regulatory effect of IL-4 and IFN-gamma of fusin/CXCR4.

Authors:  G Galli; F Annunziato; C Mavilia; P Romagnani; L Cosmi; R Manetti; C Pupilli; E Maggi; S Romagnani
Journal:  Eur J Immunol       Date:  1998-10       Impact factor: 5.532

8.  Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.

Authors:  T W Chun; D Engel; M M Berrey; T Shea; L Corey; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1998-07-21       Impact factor: 11.205

9.  Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: replication is restricted at a postentry level.

Authors:  H Schmidtmayerova; M Alfano; G Nuovo; M Bukrinsky
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

10.  Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines.

Authors:  T W Chun; D Engel; S B Mizell; L A Ehler; A S Fauci
Journal:  J Exp Med       Date:  1998-07-06       Impact factor: 14.307

View more
  17 in total

1.  Naive CD4 T cells inhibit CD28-costimulated R5 HIV replication in memory CD4 T cells.

Authors:  M Mengozzi; M Malipatlolla; S C De Rosa; L A Herzenberg; L A Herzenberg; M Roederer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-18       Impact factor: 11.205

2.  Inhibition of CD3/CD28-mediated activation of the MEK/ERK signaling pathway represses replication of X4 but not R5 human immunodeficiency virus type 1 in peripheral blood CD4(+) T lymphocytes.

Authors:  W Popik; P M Pitha
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

3.  TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.

Authors:  Anna Kajaste-Rudnitski; Sara S Marelli; Cinzia Pultrone; Thomas Pertel; Pradeep D Uchil; Nadir Mechti; Walther Mothes; Guido Poli; Jeremy Luban; Elisa Vicenzi
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

4.  Selective inhibition of HIV replication in primary macrophages but not T lymphocytes by macrophage-derived chemokine.

Authors:  M Cota; M Mengozzi; E Vicenzi; P Panina-Bordignon; F Sinigaglia; P Transidico; S Sozzani; A Mantovani; G Poli
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

5.  Amino acid starvation induces reactivation of silenced transgenes and latent HIV-1 provirus via down-regulation of histone deacetylase 4 (HDAC4).

Authors:  Ilaria Palmisano; Giulia Della Chiara; Rosa Lucia D'Ambrosio; Claudia Huichalaf; Paola Brambilla; Silvia Corbetta; Michela Riba; Rosanna Piccirillo; Sergio Valente; Giorgio Casari; Antonello Mai; Filippo Martinelli Boneschi; Davide Gabellini; Guido Poli; Maria Vittoria Schiaffino
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-23       Impact factor: 11.205

6.  Cell surface CCR5 density determines the postentry efficiency of R5 HIV-1 infection.

Authors:  Yea-Lih Lin; Clement Mettling; Pierre Portales; Jacques Reynes; Jacques Clot; Pierre Corbeau
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-14       Impact factor: 11.205

7.  Host factor transcriptional regulation contributes to preferential expression of HIV type 1 in IL-4-producing CD4 T cells.

Authors:  Mingce Zhang; Adrian Clausell; Tanya Robinson; Jiyi Yin; Eric Chen; Leanne Johnson; Greta Weiss; Steffanie Sabbaj; Robert M Lowe; Fred H Wagner; Paul A Goepfert; Olaf Kutsch; Randy Q Cron
Journal:  J Immunol       Date:  2012-08-08       Impact factor: 5.422

8.  Human immunodeficiency virus persistence and production in T-cell development.

Authors:  Kevin B Gurney; Christel H Uittenbogaart
Journal:  Clin Vaccine Immunol       Date:  2006-09-20

9.  Expression and function of chemokine receptors on human thymocytes: implications for infection by human immunodeficiency virus type 1.

Authors:  J R Taylor; K C Kimbrell; R Scoggins; M Delaney; L Wu; D Camerini
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

10.  Human prostate supports more efficient replication of HIV-1 R5 than X4 strains ex vivo.

Authors:  Anna Le Tortorec; Anne-Pascale Satie; Hélène Denis; Nathalie Rioux-Leclercq; Laurence Havard; Annick Ruffault; Bernard Jégou; Nathalie Dejucq-Rainsford
Journal:  Retrovirology       Date:  2008-12-31       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.